Results 1 to 10 of about 193,195 (180)

Coronary Microvascular Dysfunction in Cardiomyopathies: Insights on Clinical and Prognostic Roles [PDF]

open access: yesReviews in Cardiovascular Medicine
Coronary microvascular dysfunction (CMD) is a key driver of ischemia and prognosis across several non-ischemic cardiomyopathies. This review summarizes the main tools for diagnosing microvascular dysfunction and available evidence on CMD incidence and ...
Federico Giacobbe   +20 more
doaj   +2 more sources

Microvascular Dysfunction in Patients with Prediabetes: Novel Methods Identify Impaired Microcirculation [PDF]

open access: yesLife
Background: Skin and myocardial microvascular dysfunction in prediabetes remains underexplored, and limited studies have investigated the microcirculation in prediabetes in multiple vascular beds.
Stamatina Lamprou   +10 more
doaj   +2 more sources

Coronary Microvascular Dysfunction [PDF]

open access: yesArteriosclerosis, Thrombosis, and Vascular Biology, 2021
Over the past couple of decades, accumulating evidence has shown that structural and functional abnormalities of coronary microvasculature are highly prevalent, associated with adverse clinical outcomes in patients with various cardiovascular diseases. The term coronary microvascular dysfunction (CMD) has been coined to refer to this clinical condition
Shigeo Godo   +4 more
  +7 more sources

Coronary Microvascular Dysfunction

open access: yesJACC: Basic to Translational Science, 2023
Thomas H. Schindler, MD, PhD   +1 more
doaj   +2 more sources

Coronary microvascular dysfunction [PDF]

open access: yesMinerva Cardioangiologica, 2020
Patients with coronary microvascular dysfunction (CMVD) represent a widespread population and despite the good prognosis, many of them have a poor quality of life with strong limitations in their daily activities because of the angina symptoms.
Sucato V.   +4 more
  +8 more sources

Inflammation in Coronary Microvascular Dysfunction [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Chronic low-grade inflammation is involved in coronary atherosclerosis, presenting multiple clinical manifestations ranging from asymptomatic to stable angina, acute coronary syndrome, heart failure and sudden cardiac death. Coronary microvasculature consists of vessels with a diameter less than 500 μm, whose potential structural and functional ...
Marios Sagris   +7 more
openaire   +3 more sources

Coronary Microvascular Dysfunction [PDF]

open access: yesNew England Journal of Medicine, 2007
The link between myocardial ischemia and obstructive atherosclerosis is established beyond any doubt and coronary angiography has demonstrated a relationship between the severity and extent of coronary artery disease (CAD) and survival. In the past two decades, however, a number of clinical studies have highlighted the potential role of coronary ...
CAMICI , PAOLO, Crea F.
  +6 more sources

Coronary Microvascular Dysfunction

open access: yesJournal of the Society for Cardiovascular Angiography & Interventions
Coronary microvascular dysfunction (CMD) is a key mechanism underlying ischemic heart disease (IHD), yet its diagnosis and treatment remain challenging. This article presents a comprehensive overview of CMD research, covering its pathogenesis, diagnostic criteria, assessment techniques, risk factors, and therapeutic strategies.
Yader Sandoval   +33 more
  +9 more sources

A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension

open access: yesAmerican Heart Journal Plus, 2023
Microvascular dysfunction progressing to pulmonary hypertension can be a primary cause of right ventricular failure or a secondary cause because of an underlying systemic illness.
Cyrus Vahdatpour   +6 more
doaj   +1 more source

Circulating Biomarkers in Coronary Microvascular Dysfunction

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Coronary microvascular dysfunction is an underdiagnosed pathologic process that is associated with adverse clinical outcomes. Biomarkers, molecules measurable in the blood, could inform the clinician by aiding in the diagnosis and management of coronary ...
Teja Chakrala   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy